Johanna Mercier

Insider Reports History

Entity
Individual
Location
333 Lakeside Drive, Foster City, CA
Signature
/s/ Edward S. Son by Power of Attorney for Johanna Mercier
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Johanna Mercier:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GILEAD SCIENCES, INC. Chief Commercial Officer Non-qualified Stock Option (Right to Buy) 88K $6.99M $79.45 Mar 10, 2024 Direct
GILEAD SCIENCES, INC. Chief Commercial Officer Common Stock 78.1K $6.5M $83.25 Sep 12, 2024 Direct
GILEAD SCIENCES, INC. Chief Commercial Officer Restricted Stock Unit 39.9K $3.25M $81.44 Sep 10, 2024 Direct
GILEAD SCIENCES, INC. Chief Commercial Officer Restricted Stock Unit 43.7K $2.85M $65.25 Jun 10, 2024 Direct
NEUROCRINE BIOSCIENCES INC Director Common Stock 2.1K $295K $140.24 May 17, 2024 Direct
NEUROCRINE BIOSCIENCES INC Director Non-Qualified Stock Option 2.98K $219K $73.60 May 22, 2024 Direct
NEUROCRINE BIOSCIENCES INC Director Restricted Stock Unit 1.44K $204K $141.90 May 22, 2024 Direct
Arcus Biosciences, Inc. Director Common Stock 0 $0 $21.00 Jan 29, 2024 Direct

Insider Reports Filed by Johanna Mercier

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GILD GILEAD SCIENCES, INC. Sep 12, 2024 2 -$2.46M 4 Sep 13, 2024 Chief Commercial Officer
GILD GILEAD SCIENCES, INC. Sep 10, 2024 3 -$141K 4 Sep 11, 2024 Chief Commercial Officer
GILD GILEAD SCIENCES, INC. Aug 28, 2024 1 -$742K 4 Aug 29, 2024 Chief Commercial Officer
GILD GILEAD SCIENCES, INC. Aug 13, 2024 1 -$406K 4 Aug 14, 2024 Chief Commercial Officer
GILD GILEAD SCIENCES, INC. Jun 10, 2024 3 -$112K 4 Jun 11, 2024 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC May 22, 2024 2 $0 4 May 23, 2024 Director
NBIX NEUROCRINE BIOSCIENCES INC May 17, 2024 2 $0 4 May 21, 2024 Director
GILD GILEAD SCIENCES, INC. Mar 10, 2024 7 -$342K 4 Mar 11, 2024 Chief Commercial Officer
GILD GILEAD SCIENCES, INC. Jan 31, 2024 3 -$1.76M 4 Feb 2, 2024 Chief Commercial Officer
RCUS Arcus Biosciences, Inc. Jan 29, 2024 0 $0 3 Feb 7, 2024 Director
GILD GILEAD SCIENCES, INC. Jan 9, 2024 1 -$702K 4 Jan 10, 2024 Chief Commercial Officer
GILD GILEAD SCIENCES, INC. Dec 10, 2023 3 -$98.5K 4 Dec 11, 2023 Chief Commercial Officer
GILD GILEAD SCIENCES, INC. Sep 10, 2023 3 -$95.5K 4 Sep 11, 2023 Chief Commercial Officer
GILD GILEAD SCIENCES, INC. Jul 24, 2023 3 -$246K 4 Jul 25, 2023 Chief Commercial Officer
GILD GILEAD SCIENCES, INC. Jun 10, 2023 3 -$99.4K 4 Jun 12, 2023 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC May 17, 2023 2 $0 4 May 19, 2023 Director
GILD GILEAD SCIENCES, INC. Mar 10, 2023 7 -$407K 4 Mar 13, 2023 Chief Commercial Officer
GILD GILEAD SCIENCES, INC. Jan 24, 2023 3 -$1.29M 4 Jan 26, 2023 Chief Commercial Officer
GILD GILEAD SCIENCES, INC. Dec 10, 2022 3 -$40.7K 4 Dec 13, 2022 Chief Commercial Officer
GILD GILEAD SCIENCES, INC. Sep 10, 2022 3 -$29.9K 4 Sep 12, 2022 Chief Commercial Officer
GILD GILEAD SCIENCES, INC. Jul 24, 2022 3 -$195K 4 Jul 26, 2022 Chief Commercial Officer
GILD GILEAD SCIENCES, INC. Jun 10, 2022 3 -$28.1K 4 Jun 13, 2022 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC May 18, 2022 1 $0 4 May 20, 2022 Director
GILD GILEAD SCIENCES, INC. Mar 10, 2022 7 -$187K 4 Mar 14, 2022 Chief Commercial Officer
GILD GILEAD SCIENCES INC Jan 26, 2022 1 $0 4 Jan 28, 2022 Chief Commercial Officer
GILD GILEAD SCIENCES INC Jul 24, 2021 3 -$236K 4 Jul 27, 2021 Chief Commercial Officer
NBIX NEUROCRINE BIOSCIENCES INC May 19, 2021 1 $0 4 May 20, 2021 Director